InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	VENTRACOR LIMITED (VCR)
Date of Listing:	17 August 1993
Date of Delisting:	31 August 2009
Former Names:

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 31 August 2009.

Legal Status: (updated monthly)

ACN: 003 180 372ABN: 46 003 180 372
Registration Date: 17 October 1986
Deregistration Date: 07 June 2013

This entity was deregistered on 07 June 2013. It has thus ceased to exist.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This entity was deregistered on 07 June 2013. Deregistration is a Capital Gains Tax Event. In our opinion you are entitled to crystallise any capital loss in the tax year that deregistration occurs providing you have not previously done so. If you did not crystallise your loss in the tax year the entity was deregistered, you may seek to re-open that year’s assessment but anyway should seek professional advice as to how best to proceed.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

VENTRACOR LIMITED(VCR)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

	FROM	TO
MICROMEDICAL INDUSTRIES LIMITED		11/07/2002

Shareholder links

REGISTRY:

Level 21, 10 Eagle Street Brisbane QLD 4000

Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: C/- Clayton Utz , Level 28 , 71 Eagle Street , BRISBANE , QLD, AUSTRALIA, 4000
Tel: (02) 9406 3100 Fax: (02) 9406 3101

Date first listed: 17/08/1993
Company Secretary:
Sector: Health Care Equipment & Services Industry Group: XHJ
Activities: Medical device company focused on commercialising the artificial heart??? device, the VentrAssist Left Ventricular Assist Device (LVAD)

News & Events

Expand this box to read and print

company deregistered today	07/06/2013
delisted following failure to pay listing fees	31/08/2009
a loss declaration has been issued and the capital loss can therefore be claimed in the financial year the declaration is issued	19/08/2009
we have twice requested that Steven Sherman of Ferrier Hodgson confirm whether his statement of 6 July 2009 (that it is not expected there will be any return to shareholders) constitutes a declaration pursuant to Section 104-145 of ITAA 1997, but we have received no reply	31/07/2009
at a creditors meeting today it is resolved to terminate the Deed of Company Arrangement and liquidate the company - it is not expected there will be any return to shareholders but the administrator/now liquidator S J Sherman has not made a formal loss declaration as yet	06/07/2009
the DOCA has failed and operations have ceased - options are being explored - a meeting of creditors on 3 July 2009 will determine the way forward	30/06/2009
in a release which reaches the market today at 6:16pm administrators advise that a second meeting of creditors is to be held at 10:00am today - a DOCA has been proposed - if it is not approved the administrators recommend liquidation	29/05/2009
the Company has not been able to attract sufficient capital to fund its operations through to 30 June 2009 - it has accordingly appointed Mr Steven Sherman and Mr John Gothard of Ferrier Hodgson to act as administrators	19/03/2009
company reports today that the US Bridge To Transplant (BTT) Trial of the VentrAssist Left Ventricular Assist Device (LVAD) has reached a successful completion	12/03/2009
company releases its Preliminary Final Report	27/02/2009
company reports today that enrolment in the US Bridge To Transplant (BTT) Trial of the VentrAssist Left Ventricular Assist Device (LVAD) is now complete at 140 patients - the first patient was enrolled in June 2007, and thus full enrolment of the trial took approximately eighteen months	12/02/2009
the securities of Ventracor Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding the LVA4 VentraAssist LVAD, the Company's financial position and the status of discussions with third parties regarding the potential sale of the Company	10/02/2009
name changed from Micromedical Industries Limited	11/07/2002

company deregistered today	07/06/2013
delisted following failure to pay listing fees	31/08/2009
a loss declaration has been issued and the capital loss can therefore be claimed in the financial year the declaration is issued	19/08/2009
we have twice requested that Steven Sherman of Ferrier Hodgson confirm whether his statement of 6 July 2009 (that it is not expected there will be any return to shareholders) constitutes a declaration pursuant to Section 104-145 of ITAA 1997, but we have received no reply	31/07/2009
at a creditors meeting today it is resolved to terminate the Deed of Company Arrangement and liquidate the company - it is not expected there will be any return to shareholders but the administrator/now liquidator S J Sherman has not made a formal loss declaration as yet	06/07/2009
the DOCA has failed and operations have ceased - options are being explored - a meeting of creditors on 3 July 2009 will determine the way forward	30/06/2009
in a release which reaches the market today at 6:16pm administrators advise that a second meeting of creditors is to be held at 10:00am today - a DOCA has been proposed - if it is not approved the administrators recommend liquidation	29/05/2009
the Company has not been able to attract sufficient capital to fund its operations through to 30 June 2009 - it has accordingly appointed Mr Steven Sherman and Mr John Gothard of Ferrier Hodgson to act as administrators	19/03/2009
company reports today that the US Bridge To Transplant (BTT) Trial of the VentrAssist Left Ventricular Assist Device (LVAD) has reached a successful completion	12/03/2009
company releases its Preliminary Final Report	27/02/2009
company reports today that enrolment in the US Bridge To Transplant (BTT) Trial of the VentrAssist Left Ventricular Assist Device (LVAD) is now complete at 140 patients - the first patient was enrolled in June 2007, and thus full enrolment of the trial took approximately eighteen months	12/02/2009
the securities of Ventracor Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement regarding the LVA4 VentraAssist LVAD, the Company's financial position and the status of discussions with third parties regarding the potential sale of the Company	10/02/2009
name changed from Micromedical Industries Limited	11/07/2002

Your browser may reflect a date of printing in American format.

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
John Massey	Chairman
Bernadette Kerrigan	General Counsel
Jane Wilder	General Counsel
Andrew Geddes	Investor Relations
Camilla Newcombe	Company Secretary
Graeme Fallet	Company Secretary

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.